Novartis launches heart drug counter-offensive Ruby Khatun Khatun15 Nov 2017 9:45 AM ISTZURICH: Novartis plans to plow through doubts over its canakinumab drug by asking regulators this year to approve the medicine as a treatment for a...
Apollo Hospitals Q2 net dips 23 percent to Rs 71 crore Ruby Khatun Khatun15 Nov 2017 9:26 AM ISTNew Delhi: Apollo Hospitals Enterprise reported 22.92 percent dip in standalone net profit to Rs 70.90 crore for the September quarter of the current...
NPPA invites representation and suggestion on Coronary Stents Ruby Khatun Khatun14 Nov 2017 4:29 PM ISTThrough a recent notification Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National Pharmaceutical...
CureFit to expand to Delhi-NCR, invest Rs 25 crore Ruby Khatun Khatun14 Nov 2017 10:37 AM ISTNew Delhi: Health-technology startup CureFit will invest about Rs 25 crore to expand its operations to Delhi-NCR and set up 30 'Cult' premium fitness...
Abbott India Q2 profit rises 83 percent to Rs 137.52 crore Ruby Khatun Khatun14 Nov 2017 10:23 AM ISTNew Delhi: Drug firm Abbott India reported 83.31% jump in net profit to Rs137.52 crore for the September quarter on account of robust sales.It had...
Morepen Labs reports 24 percent jump in its Q2 net profit Ruby Khatun Khatun14 Nov 2017 10:16 AM ISTNew Delhi: Morepen Laboratories Ltd. has reported a stable set of numbers in the second quarter (Q2) of fiscal 2017-18. The company has registered a...
Pfizer Q2 net dips 12 percent at Rs 111.15 crore Ruby Khatun Khatun14 Nov 2017 10:00 AM ISTNew Delhi: Drug firm Pfizer reported a 12 percent dip in standalone net profit to Rs 111.15 crore for the quarter ended September 30, 2017.The company...
Novartis posts eye drug data amid play for Eylea's turf Ruby Khatun Khatun14 Nov 2017 9:45 AM ISTZURICH: Novartis's bid to move in on Bayer's and Regeneron's eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker's new...
Suven Life Sciences Q2 net up 20 percent to Rs 32 crore Ruby Khatun Khatun14 Nov 2017 9:23 AM ISTNew Delhi: Suven Life Sciences reported a 19.5 percent increase in net profit to Rs 31.74 crore for the second quarter ended September 30.The company...
CDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancer Ruby Khatun Khatun13 Nov 2017 5:39 PM ISTThrough a recent notification, Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and...
OmniActive Health eyes more takeovers, to invest Rs 150 crore Ruby Khatun Khatun13 Nov 2017 2:03 PM ISTNew Delhi: OmniActive Health Technologies, a leading nutraceutical company, is looking at more strategic acquisitions in domestic and foreign markets...
Roche MS drug Ocrevus wins European panel backing Ruby Khatun Khatun13 Nov 2017 10:02 AM ISTZURICH: Swiss drugmaker Roche on Friday won a key European panel's recommendation for its multiple sclerosis drug Ocrevus, which is on track for...
